Kisqali 600 MG daily dose 63S
Ended Awarded
- Contract number
- SPE2DB26FP4NF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,204
Award facts
- Contract value 100% obligated
- $22,203.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,203.78 to AmerisourceBergen Drug Corp for the supply of Kisqali 600 mg daily dose medication in a 63-tablet quantity. This competitively awarded, firm fixed-price delivery order was issued on October 20, 2025, with an ultimate completion date of October 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a prime contractor for the DLA's comprehensive pharmaceutical supply chain supporting military and veteran healthcare systems globally. The SPE2DX IDC vehicle enables the company to supply a diverse portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. This delivery order for Kisqali, a specialized oncology medication, reflects AmerisourceBergen's role in fulfilling critical pharmaceutical needs within the federal medical supply chain through the DLA's pharmaceutical prime vendor program structure.
Quick answers
Who was awarded contract SPE2DB26FP4NF?
SPE2DB26FP4NF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FP4NF worth?
The government has obligated $22,204 on SPE2DB26FP4NF.
Is contract SPE2DB26FP4NF an order under another contract?
Yes. SPE2DB26FP4NF is a delivery order under SPE2DB25D3109, an indefinite delivery contract.
Was contract SPE2DB26FP4NF competed?
The extent of competition for SPE2DB26FP4NF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award